ATE326867T1 - Freie aminosäure enthaltende zusammensetzung - Google Patents

Freie aminosäure enthaltende zusammensetzung

Info

Publication number
ATE326867T1
ATE326867T1 AT01915386T AT01915386T ATE326867T1 AT E326867 T1 ATE326867 T1 AT E326867T1 AT 01915386 T AT01915386 T AT 01915386T AT 01915386 T AT01915386 T AT 01915386T AT E326867 T1 ATE326867 T1 AT E326867T1
Authority
AT
Austria
Prior art keywords
free amino
amino acid
composition containing
containing free
administering
Prior art date
Application number
AT01915386T
Other languages
English (en)
Inventor
Constance Whippie
Olivier Ballevre
Julio Boza
Paul-Andre Finot
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE326867T1 publication Critical patent/ATE326867T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
AT01915386T 2000-04-12 2001-03-21 Freie aminosäure enthaltende zusammensetzung ATE326867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0009056.3A GB0009056D0 (en) 2000-04-12 2000-04-12 Composition comprising free amino acids

Publications (1)

Publication Number Publication Date
ATE326867T1 true ATE326867T1 (de) 2006-06-15

Family

ID=9889802

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01915386T ATE326867T1 (de) 2000-04-12 2001-03-21 Freie aminosäure enthaltende zusammensetzung

Country Status (17)

Country Link
US (3) US20040096478A1 (de)
EP (1) EP1274322B1 (de)
JP (1) JP5600232B2 (de)
KR (1) KR20020089448A (de)
CN (1) CN1243542C (de)
AT (1) ATE326867T1 (de)
CA (1) CA2404005C (de)
DE (1) DE60119919T2 (de)
ES (1) ES2263602T3 (de)
GB (1) GB0009056D0 (de)
HK (1) HK1054489A1 (de)
HU (1) HUP0300299A3 (de)
MX (1) MXPA02010058A (de)
NO (1) NO324525B1 (de)
PL (1) PL358876A1 (de)
RU (1) RU2002130204A (de)
WO (1) WO2001078532A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
US6592908B1 (en) * 2002-09-23 2003-07-15 Albert Crum Nutritional or therapeutic compositions
PT1638418E (pt) 2003-06-23 2012-09-20 Nestec Sa Suplementação de aminoácidos para um ecossistema de flora microbiana saudável
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
DK1543735T3 (en) * 2003-12-20 2015-11-02 Nestec Sa FOOD COMPOSITION FOR HEALTH CARE
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
EP1767201B8 (de) 2004-06-28 2012-02-29 Ajinomoto Co., Inc. Nährstoffzusammensetzung und zusammensetzung zur prävention/mitigation von verdauungstraktdepression
MX2007003196A (es) * 2004-09-17 2007-05-16 Ajinomoto Kk Agente y alimento para evitar/mejorar el trastorno digestivo funcional.
WO2006134135A2 (en) * 2005-06-14 2006-12-21 Nestec S.A. Nutritional method for elderly people
EP1920770A4 (de) * 2005-07-01 2010-09-29 Ajinomoto Kk Therapeutisches mittel gegen entzündliche darmerkrankung und tnf-alpha-produktionshemmer
JP4916143B2 (ja) * 2005-08-04 2012-04-11 サッポロビール株式会社 ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物
RU2390272C2 (ru) 2005-08-29 2010-05-27 Адзиномото Ко., Инк. Питательная композиция
US8722120B2 (en) 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations
EP2263666A4 (de) * 2008-03-11 2011-11-09 Ajinomoto Kk Mittel und nahrungsmittel zur prävention/linderung von funktionalen magen-darm-erkrankungen
WO2011021926A1 (en) * 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
US20120308525A1 (en) * 2009-11-25 2012-12-06 Nestec S.A. Nutritional compositions including a high protein component and exogenous nucleotides
JP2011121889A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121888A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121887A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011144116A (ja) * 2010-01-12 2011-07-28 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用添加剤
BR112013006044B1 (pt) 2010-09-24 2022-03-29 University Of Florida Research Foundation, Inc Composição terapêutica para administração enteral compreendendo como aminoácidos livres, serina e valina, bem como embalagem contendo a dita composição
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
CA2904046C (en) 2013-03-11 2020-01-14 University Of Florida Research Foundation, Incorporated Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
WO2015108157A1 (ja) * 2014-01-17 2015-07-23 株式会社明治 食後早期飽満感または胃食道逆流症の予防または改善剤
JP6693413B2 (ja) * 2014-04-30 2020-05-13 味の素株式会社 消化管障害を改善する組成物
EP3616689A1 (de) 2014-11-24 2020-03-04 Entrinsic Health Solutions, Inc. Aminosäurezusammensetzungen zur behandlung der symptome einer krankheit
CA2981757C (en) * 2015-05-14 2023-06-27 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
WO2016199798A1 (ja) * 2015-06-10 2016-12-15 味の素株式会社 運動誘発性の消化管障害の改善剤
EP3310354A4 (de) 2015-06-17 2018-12-12 Dispersol Technologies, LLC Verbesserte formulierungen von deferasirox und verfahren zur herstellung davon
CN105747214A (zh) * 2016-02-26 2016-07-13 四川安益生物科技有限公司 一种支链氨基酸组合物
MX2019003821A (es) 2016-10-04 2019-12-18 Univ Florida Composiciones de aminoacidos y usos de las mismas.
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
DE102017201713A1 (de) 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
CA3061158A1 (en) * 2017-04-25 2018-11-01 Almeda Labs Llc Amino acid formulations for pancreatic viability
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
JP2019058140A (ja) * 2017-09-27 2019-04-18 味の素株式会社 栄養組成物
TW201932483A (zh) * 2018-01-16 2019-08-16 林文欽 用於形成膠原蛋白的氨基酸組成物
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
CN111067885A (zh) * 2020-02-20 2020-04-28 杨益文 一种消除幽门螺旋螺杆菌及治疗胃及十二指肠溃疡的药物
WO2021178860A1 (en) * 2020-03-06 2021-09-10 Axcella Health Inc. Amino acid compositions and methods for muscle and myotube modulation
WO2023066831A1 (en) * 2021-10-21 2023-04-27 Société des Produits Nestlé S.A. Composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT945910B (it) * 1971-04-08 1973-05-10 Erra C Spa Prodotto dietetico impiegabile quale intergratore dell alimenta zione umana con particolare riferi mento all infanzia agli stati di convalescenza di gravidanza d allat tamento e dell eta senile e procedi mento per la sua fabbricazione
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4053589A (en) * 1975-11-24 1977-10-11 Control Drug Inc. Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
GB2223925A (en) * 1988-09-09 1990-04-25 Stiff John Edward Dietary supplements
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
US5106836A (en) * 1991-02-22 1992-04-21 Clintec Nutrition Co. Enteral diet
WO1994014458A1 (en) * 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
RU2091067C1 (ru) * 1994-05-30 1997-09-27 Мыслицкая Людмила Николаевна Способ лечения желудочно-кишечных заболеваний
RU2080871C1 (ru) * 1994-05-30 1997-06-10 Макаров Николай Васильевич Средство, обладающее регенеративной активностью
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
WO1998054985A1 (en) 1997-06-02 1998-12-10 Societe Des Produits Nestle S.A. Product and method for providing glutamine
EP1024709B1 (de) 1997-09-16 2006-06-14 Societe Des Produits Nestle S.A. Verwendung eines organspezifischen ernährungmittels

Also Published As

Publication number Publication date
US20060247312A1 (en) 2006-11-02
US8067471B2 (en) 2011-11-29
NO20024743L (no) 2002-12-03
HK1054489A1 (zh) 2003-12-05
NO324525B1 (no) 2007-11-12
RU2002130204A (ru) 2004-03-27
CA2404005A1 (en) 2001-10-25
HUP0300299A2 (hu) 2003-07-28
EP1274322A1 (de) 2003-01-15
EP1274322B1 (de) 2006-05-24
CN1243542C (zh) 2006-03-01
JP5600232B2 (ja) 2014-10-01
MXPA02010058A (es) 2003-03-10
DE60119919T2 (de) 2007-04-26
JP2003530411A (ja) 2003-10-14
GB0009056D0 (en) 2000-05-31
HUP0300299A3 (en) 2005-01-28
PL358876A1 (en) 2004-08-23
KR20020089448A (ko) 2002-11-29
US20040096478A1 (en) 2004-05-20
NO20024743D0 (no) 2002-10-02
ES2263602T3 (es) 2006-12-16
CA2404005C (en) 2009-12-08
DE60119919D1 (de) 2006-06-29
US8383680B2 (en) 2013-02-26
CN1422125A (zh) 2003-06-04
WO2001078532A1 (en) 2001-10-25
US20120035234A1 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
ATE326867T1 (de) Freie aminosäure enthaltende zusammensetzung
CA2219502A1 (en) Methods and formulations for modulating the human sexual response
HUP9701540A1 (hu) A gasztrointesztinális keringést elősegítő gyógyászati készítmény
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
CA2255652A1 (en) Isobutylgaba and its derivatives for the treatment of pain
DE122006000051I2 (de) Ester der 5-Aminolevulinsäure als Mittel zur Photosensibilisierung in der Chemotherapie
DE69617719D1 (de) Pharmazeutische zusammensetzung von stickstoffmonoxid
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
DE59811158D1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
FI940659A0 (fi) Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
KR910007858A (ko) 초기-촉진 및 향상된 진통제로서의 s(+)-이부프로펜-l-아미노산 및 s(+)-이부프로펜-d-아미노산
DE69614375D1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
ATE184788T1 (de) Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
HUP0202525A2 (hu) Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
FR2618439B1 (fr) Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
MD1469G2 (ro) Metodă de tratament al şocului combustional
GEP20053457B (en) Low Hygroscopic Aripiprazole Drug Substance and Processes for Preparation Thereof
HUP0200148A2 (hu) N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére
UA41652A (uk) Спосіб лікування хворих на гіпертонічну хворобу

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties